Sana Biotechnology, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Sana Biotechnology, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2020 to Q4 2023.
  • Sana Biotechnology, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $403M, a 46.8% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $403M +$128M +46.8% Dec 31, 2023 10-K 2024-02-29
Q4 2022 $274M +$118M +75.2% Dec 31, 2022 10-K 2024-02-29
Q4 2021 $157M +$85.6M +121% Dec 31, 2021 10-K 2023-03-16
Q4 2020 $71M Dec 31, 2020 10-K 2022-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.